Home > Insider Trading > Filing (0001209191-15-078179)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1197032	F Ian Smith	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2015-10-30	2,800	$124.95	115,334	No	4	S	Direct
Common Stock	Disposition	2015-10-30	4,865	$125.98	110,469	No	4	S	Direct
Common Stock	Disposition	2015-10-30	2,685	$126.62	107,784	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,306	Indirect	401(k)

Footnotes

Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.
Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $124.95 (range $124.33 to $125.30).
Open market sales reported on this line occurred at a weighted average price of $125.98 (range $125.33 to $126.28).
Open market sales reported on this line occurred at a weighted average price of $126.62 (range $126.34 to $126.93).